Physician

Abraham Raza Khan, M.D.

According to 2025 Medicare claims, Abraham Khan, M.D. (NPI: 1942405709) practices gastroenterology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is NEW YORK UNIVERSITY (NPI: 1285826438; TIN: 472665045) and primary practice location at 10016-2708.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 356 traditional Medicare patients, billed 739 HCPCS/CPT codes, and received $103,273 in Medicare payments. The top billing code was 91010 (Study of esophagus to assess movement). Part D data shows 783 prescription claims across 225 beneficiaries totaling $137,416 in drug costs, led by Dexlansoprazole Dr (Dexlansoprazole). 2016 DME data shows 13 claims. Open Payments data shows 25 records totaling $35,244. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $30,298 to $137,416. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	285	816	$97,758
2016	312	814	$92,104
2017	373	859	$103,585
2018	394	853	$116,419
2019	387	808	$127,534
2020	307	647	$99,227
2021	340	801	$127,756
2022	356	847	$131,366
2023	335	788	$123,273
2024	356	739	$103,273

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	112	407	$30,298
2016	156	608	$58,464
2017	165	705	$40,141
2018	230	1,025	$43,784
2019	251	1,121	$77,543
2020	255	1,042	$89,350
2021	250	1,106	$118,729
2022	276	1,120	$149,241
2023	275	1,104	$159,606
2024	225	783	$137,416

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	13	$1,644
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
91010	Study of esophagus to assess movement	43	43	$191
91037	Monitoring and recording of esophageal function through nasal tube with electrode	41	41	$153
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	78	78	$137
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	109	111	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	239	294	$109

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dexlansoprazole Dr	Dexlansoprazole	102	5,100	$25,459
Voquezna	Vonoprazan Fumarate	18	540	$11,464
Linzess	Linaclotide	12	360	$6,079
Omeprazole	Omeprazole	209	14,880	$3,110
Esomeprazole Magnesium	Esomeprazole Magnesium	70	3,692	$2,783

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$23,744	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$11,500	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abraham Raza Khan, M.D.?

Tedicare shows public-source Medicare data for Abraham Raza Khan, M.D. (NPI 1942405709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abraham Raza Khan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abraham Raza Khan, M.D.?

Abraham Raza Khan, M.D. is linked to NEW YORK UNIVERSITY (billing NPI 1285826438) in the available physician profile data.

Does Abraham Raza Khan, M.D. have Open Payments data?

Abraham Raza Khan, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.